You are using an outdated browser. Please upgrade your browser to improve your experience.

Tdark
ARL17A
ADP-ribosylation factor-like protein 17

Protein Summary
Description
GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus (By similarity).
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000336125
  • ENSP00000337478
  • ENSG00000185829
  • ENST00000434041
  • ENSP00000391751
  • ENSG00000228696
  • ENST00000445552
  • ENSP00000416535
  • ENST00000450673
  • ENSP00000404247
  • ENST00000570618
  • ENSP00000459151
  • ENST00000613440
  • ENSP00000482789
  • ENSG00000275748
  • ENST00000615623
  • ENSP00000482856
  • ENSG00000276276
  • ENST00000617818
  • ENSP00000479224
  • ENST00000618729
  • ENSP00000483271
  • ENST00000622165
  • ENSP00000481838
  • ENST00000626328
  • ENSP00000487334
  • ENST00000634170
  • ENSP00000487605

Symbol
  • ARL17P1
  • ARL17
  • ARL17A
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
tissue sample
0.64
cell line
0.6
tissue
0.6
cell type or tissue
0.56
microRNA
0.48


Protein Classes
No PANTHER Classes or DTO Classes found
IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 6.26   (req: < 5)
Gene RIFs: 0   (req: <= 3)
Antibodies: 31   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 6.26   (req: >= 5)
Gene RIFs: 0   (req: > 3)
Antibodies: 31   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 3
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0